Back
HFA Premium Access

In HFrEF patients, reduced doses of sacubitril / valsartan do not result in increased mortality or heart failure hospitalizations compared to target dose. A retrospective cohort study

Session: Poster Session 3 - Chronic Heart Failure – Treatment
Topic: Pharmacotherapy
Speaker: Doctor R. De Vecchis (Naples, IT)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Renato De Vecchis

Hospital San Gennaro - ASL Napoli 1 Centre, Naples (Italy)
4 presentations
0 follower

38 more presentations in this session

Tertiary heart failure care in the netherlands: what is the added value

Speaker: Miss M. Vester (Leiden, NL)

Access
Abstract
Slides
Like
Thumbnail

The protective effect of beta-blockers in 3,278 advanced heart failure patients treated with continuous inotropes

Speaker: Doctor O. Havakuk (Tel Aviv, IL)

Access
Abstract
Like
Thumbnail

The benefits of ivabradine in the management of angina pectoris and heart failure.

Speaker: Doctor Z. RAISSUNI (Tanger, MA)

Access
Abstract
Like
Thumbnail

Anti diabetic therapy in patients with heart failure and type 2 diabetes mellitus in general population.

Access
Like
Thumbnail

The association between adherence to evidence-based medicines and outcomes in seniors with heart failure: a landmark analysis

Access
Like
Thumbnail

Access the full session

Poster Session 3 - Chronic Heart Failure – Treatment

Speakers: Doctor R. De Vecchis, Miss M. Vester, Doctor O. Havakuk, Doctor Z. RAISSUNI
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources